Long Focus Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-31,100
Closed -$9.1M – 92
2026
Q1
$9.1M Sell
31,100
-30,100
-49% -$9.89M 0.24% 70
2025
Q4
$21.5M Sell
61,200
-25,800
-30% -$8.72M 0.56% 49
2025
Q3
$28.1M Buy
+87,000
New +$27.1M 0.93% 31

Other funds holding ELV

Long Focus Capital Management's ELV Position: Q2 2026 in Review

Long Focus Capital Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 31,100 shares — an estimated $9.1M sold.

Long Focus Capital Management first reported a position in ELV in Q3 2025 and held it in 3 quarters. The position peaked at $28.1M in Q3 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Long Focus Capital Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Long Focus Capital Management sold 31,100 Elevance Health shares in Q2 2026, an estimated $9.1M.
  • Long Focus Capital Management first reported a position in Elevance Health in Q3 2025 and held it in 3 quarters.
  • Long Focus Capital Management's Elevance Health position peaked at $28.1M in Q3 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Long Focus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.